Peng Cao
- Molecular Biology
- Epidemiology
- Infectious Diseases top 10%
- Plant Science
- Modeling and Simulation top 2%
- Co-authors
- Kaiping WangYu ZhangHanxiang WangJianying ChenBo ZhangMitchell A. SullivanWei LiKaixiong Tao
- Topics
- Drug-Induced Hepatotoxicity and Protection (4 papers)SARS-CoV-2 and COVID-19 Research (3 papers)COVID-19 Clinical Research Studies (3 papers)
- Journals
- SHILAP Revista de lepidopterologíaClinical Infectious DiseasesScientific Reports
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Peng Cao
28 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 114
- Molecular Biology 301
- Epidemiology 213
- Infectious Diseases 204
- Plant Science 170
- Modeling and Simulation 166
Countries citing papers authored by Peng Cao
This map shows the geographic impact of Peng Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Cao more than expected).
Fields of papers citing papers by Peng Cao
This network shows the impact of papers produced by Peng Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Cao. The network helps show where Peng Cao may publish in the future.
Co-authorship network of co-authors of Peng Cao
This figure shows the co-authorship network connecting the top 25 collaborators of Peng Cao. A scholar is included among the top collaborators of Peng Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Cao. Peng Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 0 | |
| 8 | 7 | |
| 9 | 3 | |
| 10 | 12 | |
| 11 | 67 | |
| 12 | 17 | |
| 13 | 7 | |
| 14 | 10 | |
| 15 | 20 | |
| 16 | 86 | |
| 17 | 119 | |
| 18 | 36 | |
| 19 | 56 | |
| 20 | 54 |
About Peng Cao
Peng Cao is a scholar working on Biological Psychiatry, Pharmacology and Applied Microbiology and Biotechnology, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Modeling and Simulation (166 citations), Pharmacology (134 citations) and Complementary and alternative medicine (98 citations). Peng Cao has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Kaiping Wang, Yu Zhang, Hanxiang Wang, Jianying Chen, Bo Zhang, Mitchell A. Sullivan, Wei Li, Kaixiong Tao, Peng Zhang and Xinghua Liu. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.